| Website | cibiem.com |
| Category | BioTech |
| Phone | 212-929-6600 |
| Employees | |
| Description | A medical device company |
| TOTAL | $10M |
| FUNDING TOTAL | $10M |
| Series A, 10/12 SV Life Sciences Third Rock Ventures | $10M |
Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation™ (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. The company was co-founded by Mark Gelfand and Howard R. Levin, M.D., the proven team of innovators and entrepreneurs behind Coridea. The company is backed by top-tier venture investors Third Rock Ventures and SV Life Sciences.
